Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Oncology Institute (TOI) EPS (Basic): 2020-2024

Historic EPS (Basic) for Oncology Institute (TOI) over the last 5 years, with FY2024 value amounting to -$0.71.

  • Oncology Institute's EPS (Basic) rose 2222.22% to -$0.14 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.14, marking a year-over-year increase of 2222.22%. This contributed to the annual value of -$0.71 for FY2024, which is 2282.61% up from last year.
  • As of FY2024, Oncology Institute's EPS (Basic) stood at -$0.71, which was up 2282.61% from -$0.92 recorded in FY2023.
  • Oncology Institute's EPS (Basic)'s 5-year high stood at -$0.16 during FY2021, with a 5-year trough of -$0.92 in FY2023.
  • Its 5-year average for EPS (Basic) is -$0.45, with a median of -$0.24 in 2020.
  • As far as peak fluctuations go, Oncology Institute's EPS (Basic) soared by 3333.33% in 2021, and later tumbled by 29440.53% in 2023.
  • Oncology Institute's EPS (Basic) (Annual) stood at -$0.24 in 2020, then soared by 33.33% to -$0.16 in 2021, then plummeted by 45.79% to -$0.23 in 2022, then crashed by 294.41% to -$0.92 in 2023, then rose by 22.83% to -$0.71 in 2024.
  • Its EPS (Basic) was -$0.71 in FY2024, compared to -$0.92 in FY2023 and -$0.23 in FY2022.